Upgrade to SI Premium - Free Trial

Intellia Therapeutics (NTLA) PT Raised to $30 at Chardan

April 27, 2026 2:50 PM
Chardan analyst Geulah Livshits raised the price target on Intellia Therapeutics (NASDAQ: NTLA) to $30.00 (from $27.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change